Mark A. Schmetz

530 total citations
11 papers, 429 citations indexed

About

Mark A. Schmetz is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Surgery. According to data from OpenAlex, Mark A. Schmetz has authored 11 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in Mark A. Schmetz's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Complement system in diseases (3 papers) and Escherichia coli research studies (3 papers). Mark A. Schmetz is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Complement system in diseases (3 papers) and Escherichia coli research studies (3 papers). Mark A. Schmetz collaborates with scholars based in United States and United Kingdom. Mark A. Schmetz's co-authors include Keith A. Joiner, L Leive, Nili Grossman, M M Frank, John Foulds, Carl H. Hammer, Robert C. Goldman, Martin Frank, V. Jiménez-Lucho and Martin E. Sanders and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Mark A. Schmetz

10 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Schmetz United States 9 165 130 98 81 71 11 429
John N. Goldman United States 8 175 1.1× 67 0.5× 104 1.1× 35 0.4× 135 1.9× 23 417
Kathryn Nixdorff Germany 12 169 1.0× 55 0.4× 179 1.8× 43 0.5× 36 0.5× 33 423
Homma Jy Japan 11 64 0.4× 83 0.6× 181 1.8× 77 1.0× 44 0.6× 51 367
M Purvén Sweden 7 43 0.3× 56 0.4× 57 0.6× 130 1.6× 86 1.2× 8 398
Lina Guerra Sweden 8 87 0.5× 74 0.6× 286 2.9× 38 0.5× 46 0.6× 8 535
J. Pohlner Germany 7 75 0.5× 146 1.1× 214 2.2× 192 2.4× 50 0.7× 8 528
P. G. Detilleux United States 9 108 0.7× 199 1.5× 119 1.2× 13 0.2× 104 1.5× 10 462
Hilo Yen Japan 11 123 0.7× 196 1.5× 206 2.1× 30 0.4× 20 0.3× 14 469
Philip A. Coull United Kingdom 7 148 0.9× 43 0.3× 77 0.8× 195 2.4× 150 2.1× 9 346
Gerd Lipowsky Latvia 8 109 0.7× 51 0.4× 171 1.7× 42 0.5× 86 1.2× 8 424

Countries citing papers authored by Mark A. Schmetz

Since Specialization
Citations

This map shows the geographic impact of Mark A. Schmetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Schmetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Schmetz more than expected).

Fields of papers citing papers by Mark A. Schmetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Schmetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Schmetz. The network helps show where Mark A. Schmetz may publish in the future.

Co-authorship network of co-authors of Mark A. Schmetz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Schmetz. A scholar is included among the top collaborators of Mark A. Schmetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Schmetz. Mark A. Schmetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Herring, Judi C., et al.. (1997). Renal Medullary Carcinoma: A Recently Described Highly Aggressive Renal Tumor in Young Black Patients. The Journal of Urology. 157(6). 2246–2247. 19 indexed citations
2.
Herring, Judi C., et al.. (1997). Renal Medullary Carcinoma. The Journal of Urology. 2246–2247. 2 indexed citations
3.
Miller, Donald L., et al.. (1996). How I do it: Percutaneous biliary stents for palliation of hilar malignancies. Journal of Surgical Oncology. 62(3). 226–227.
4.
Grossman, Nili, Mark A. Schmetz, John Foulds, et al.. (1987). Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. Journal of Bacteriology. 169(2). 856–863. 103 indexed citations
5.
Schmetz, Mark A., et al.. (1987). Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.. The Journal of Immunology. 138(3). 842–848. 26 indexed citations
6.
Joiner, Keith A., Nili Grossman, Mark A. Schmetz, & L Leive. (1986). C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo.. The Journal of Immunology. 136(2). 710–715. 98 indexed citations
7.
Joiner, Keith A., Louis Fries, Mark A. Schmetz, & Martin Frank. (1985). IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.. The Journal of Experimental Medicine. 162(3). 877–889. 28 indexed citations
8.
Sanders, Martin E., Mark A. Schmetz, Carl H. Hammer, Michael M. Frank, & Keith A. Joiner. (1985). Quantitation of activation of the human terminal complement pathway by ELISA. Journal of Immunological Methods. 85(2). 245–256. 19 indexed citations
9.
Joiner, Keith A., Mark A. Schmetz, Martin E. Sanders, et al.. (1985). Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.. Proceedings of the National Academy of Sciences. 82(14). 4808–4812. 46 indexed citations
10.
Joiner, Keith A., Mark A. Schmetz, Robert C. Goldman, L Leive, & M M Frank. (1984). Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infection and Immunity. 45(1). 113–117. 43 indexed citations
11.
Joiner, Keith A., Robert C. Goldman, Mark A. Schmetz, et al.. (1984). A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.. The Journal of Immunology. 132(1). 369–375. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026